With fresh $155M round, Gilead's former top scientist moves forward with cancer-fighting startup By: San Francisco Business Times via Business Journals August 24, 2020 at 09:00 AM EDT Kronos Bio plans to take its lead cancer drug into a pivotal trial next year. Read More >>